Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
暂无分享,去创建一个
[1] J. Reynolds,et al. Cyto‐histo correlation and false‐negative urine: Before and after the Paris system for reporting urinary cytology , 2020, Diagnostic cytopathology.
[2] D. Chhieng,et al. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection , 2018, Cytopathology : official journal of the British Society for Clinical Cytology.
[3] C. VandenBussche,et al. Improved risk stratification for patients with high‐grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology , 2017, Cancer cytopathology.
[4] G. Fernandes,et al. Utility of the Paris System in Reporting Urine Cytology , 2017, Acta Cytologica.
[5] A. Chandra,et al. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion® FISH , 2017, Cytopathology : official journal of the British Society for Clinical Cytology.
[6] L. Pantanowitz,et al. Cytohistologic correlation of recurrent urothelial carcinoma detected in urinary diversion specimens , 2017, Cancer cytopathology.
[7] A. Fischer,et al. Causes of false‐negative for high‐grade urothelial carcinoma in urine cytology , 2016, Diagnostic cytopathology.
[8] R. Granados,et al. Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations , 2016, Acta Cytologica.
[9] F. Brimo,et al. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology: A Correlative Study of 124 Cases. , 2016, American Journal of Clinical Pathology.
[10] S. Pambuccian,et al. Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion , 2016, Cancer cytopathology.
[11] Anirban P. Mitra,et al. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. , 2014, Urology.
[12] F. Mege-Lechevallier,et al. Diagnostic terminology for urinary cytology reports including the new subcategories ‘atypical urothelial cells of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’ (AUC‐H) , 2014, Cytopathology : official journal of the British Society for Clinical Cytology.
[13] G. Barkan,et al. Evaluation of atypical urine cytology progression to malignancy , 2013, Cancer cytopathology.
[14] C. VandenBussche,et al. The Johns Hopkins Hospital template for urologic cytology samples , 2013, Cancer cytopathology.
[15] C. VandenBussche,et al. The Johns Hopkins Hospital template for urologic cytology samples , 2013, Cancer cytopathology.
[16] L. Carmignani,et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. , 2012, The Journal of urology.
[17] F. Brimo,et al. Accuracy of urine cytology and the significance of an atypical category. , 2009, American journal of clinical pathology.
[18] A. Renshaw. Subclassifying atypical urinary cytology specimens , 2000, Cancer.
[19] S. Groshen,et al. Urethral recurrence in patients with orthotopic ileal neobladders. , 1996, The Journal of urology.
[20] D. Esrig,et al. Management of the patient with bladder cancer. Urethral recurrence. , 1994, The Urologic clinics of North America.
[21] M. Quek,et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology , 2016, Acta Cytologica.
[22] A. Vickers,et al. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. , 2008, The Journal of urology.